---
schema_version: "secwatch.filing_event.v1"
accession: "0001819790-24-000024"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2024-03-05T23:59:59+00:00"
generated_at: "2026-06-05T04:00:21.117277+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tarsus Pharmaceuticals completes public offering, raising net proceeds of $107.8M

## Summary
- Sold 3,281,250 shares and pre-funded warrants for 312,500 shares at $32.00 public price.
- Underwriters exercised option in full to purchase additional 468,750 shares.
- Net proceeds after discounts and expenses were approximately $107.8 million.
- Offering closed March 5, 2024; led by Goldman Sachs, BofA Securities, Guggenheim Securities.

## SEC filing metadata
- accession: 0001819790-24-000024
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2024-03-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000181979024000024/0001819790-24-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000181979024000024/tars-20240305.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001819790-24-000024
- JSON: https://secwatch.observer/filing/0001819790-24-000024.json
- Plain text: https://secwatch.observer/filing/0001819790-24-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.